Literature DB >> 33663953

Context-Dependent Glioblastoma-Macrophage/Microglia Symbiosis and Associated Mechanisms.

Wenjing Xuan1, Maciej S Lesniak1, Charles David James1, Amy B Heimberger2, Peiwen Chen3.   

Abstract

Glioblastoma (GBM) is a lethal form of primary brain tumor in human adults. The impact of tumor-intrinsic alterations is not exclusively confined to cancer cells but can also be extended to the tumor microenvironment (TME). Glioblastoma-associated macrophages/microglia (GAMs) are a prominent type of immune cells that account for up to 50% of total cells in GBM. Emerging evidence suggests that context-dependent GBM-GAM symbiotic interactions are pivotal for tumor growth and progression. Here, we discuss how specific genetic alterations in GBM cells affect GAM biology and, reciprocally, how GAMs support GBM progression. We hypothesize that understanding context-dependent GBM-GAM symbiosis may reveal the molecular basis of GBM tumorigenesis and lead to novel candidate treatment approaches aiming to improve GBM patient outcomes.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  crosstalk; glioblastoma; heterogeneity; macrophages; microglia; symbiosis

Mesh:

Year:  2021        PMID: 33663953      PMCID: PMC8005482          DOI: 10.1016/j.it.2021.02.004

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  95 in total

1.  PTEN controls tumor-induced angiogenesis.

Authors:  S Wen; J Stolarov; M P Myers; J D Su; M H Wigler; N K Tonks; D L Durden
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.

Authors:  Junfei Zhao; Andrew X Chen; Robyn D Gartrell; Andrew M Silverman; Luis Aparicio; Tim Chu; Darius Bordbar; David Shan; Jorge Samanamud; Aayushi Mahajan; Ioan Filip; Rose Orenbuch; Morgan Goetz; Jonathan T Yamaguchi; Michael Cloney; Craig Horbinski; Rimas V Lukas; Jeffrey Raizer; Ali I Rae; Jinzhou Yuan; Peter Canoll; Jeffrey N Bruce; Yvonne M Saenger; Peter Sims; Fabio M Iwamoto; Adam M Sonabend; Raul Rabadan
Journal:  Nat Med       Date:  2019-02-11       Impact factor: 53.440

Review 3.  Therapy for glioblastoma: is it working?

Authors:  Edward D Zanders; Fredrik Svensson; David S Bailey
Journal:  Drug Discov Today       Date:  2019-03-13       Impact factor: 7.851

Review 4.  PARP inhibitors: Synthetic lethality in the clinic.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  Science       Date:  2017-03-16       Impact factor: 47.728

5.  Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival.

Authors:  Jonas Kloepper; Lars Riedemann; Zohreh Amoozgar; Giorgio Seano; Katharina Susek; Veronica Yu; Nisha Dalvie; Robin L Amelung; Meenal Datta; Jonathan W Song; Vasileios Askoxylakis; Jennie W Taylor; Christine Lu-Emerson; Ana Batista; Nathaniel D Kirkpatrick; Keehoon Jung; Matija Snuderl; Alona Muzikansky; Kay G Stubenrauch; Oliver Krieter; Hiroaki Wakimoto; Lei Xu; Lance L Munn; Dan G Duda; Dai Fukumura; Tracy T Batchelor; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-04       Impact factor: 11.205

6.  Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma.

Authors:  Aparna Bhaduri; Elizabeth Di Lullo; Diane Jung; Sören Müller; Elizabeth Erin Crouch; Carmen Sandoval Espinosa; Tomoko Ozawa; Beatriz Alvarado; Julien Spatazza; Cathryn René Cadwell; Grace Wilkins; Dmitry Velmeshev; Siyuan John Liu; Martina Malatesta; Madeline Gail Andrews; Mohammed Andres Mostajo-Radji; Eric Jinsheng Huang; Tomasz Jan Nowakowski; Daniel Amos Lim; Aaron Diaz; David Ronan Raleigh; Arnold Richard Kriegstein
Journal:  Cell Stem Cell       Date:  2020-01-02       Impact factor: 24.633

7.  Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.

Authors:  Benjamin G Bitler; Katherine M Aird; Azat Garipov; Hua Li; Michael Amatangelo; Andrew V Kossenkov; David C Schultz; Qin Liu; Ie-Ming Shih; Jose R Conejo-Garcia; David W Speicher; Rugang Zhang
Journal:  Nat Med       Date:  2015-02-16       Impact factor: 53.440

8.  Tumor-associated macrophage interleukin-β promotes glycerol-3-phosphate dehydrogenase activation, glycolysis and tumorigenesis in glioma cells.

Authors:  Jian Lu; Zhongye Xu; Hubin Duan; Hongming Ji; Zigang Zhen; Bo Li; Huangsuo Wang; Huoquan Tang; Jie Zhou; Tao Guo; Bin Wu; Dawei Wang; Yueting Liu; Yuhu Niu; Ruisheng Zhang
Journal:  Cancer Sci       Date:  2020-05-21       Impact factor: 6.716

Review 9.  Cancer Stemness Meets Immunity: From Mechanism to Therapy.

Authors:  Peiwen Chen; Wen-Hao Hsu; Jincheng Han; Yan Xia; Ronald A DePinho
Journal:  Cell Rep       Date:  2021-01-05       Impact factor: 9.423

10.  Macrophage activation and polarization: nomenclature and experimental guidelines.

Authors:  Peter J Murray; Judith E Allen; Subhra K Biswas; Edward A Fisher; Derek W Gilroy; Sergij Goerdt; Siamon Gordon; John A Hamilton; Lionel B Ivashkiv; Toby Lawrence; Massimo Locati; Alberto Mantovani; Fernando O Martinez; Jean-Louis Mege; David M Mosser; Gioacchino Natoli; Jeroen P Saeij; Joachim L Schultze; Kari Ann Shirey; Antonio Sica; Jill Suttles; Irina Udalova; Jo A van Ginderachter; Stefanie N Vogel; Thomas A Wynn
Journal:  Immunity       Date:  2014-07-17       Impact factor: 31.745

View more
  11 in total

Review 1.  Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma.

Authors:  Lizhi Pang; Fatima Khan; Amy B Heimberger; Peiwen Chen
Journal:  Trends Cancer       Date:  2022-05-24

Review 2.  Pharmacological targeting of the tumor-immune symbiosis in glioblastoma.

Authors:  Lizhi Pang; Fatima Khan; Madeline Dunterman; Peiwen Chen
Journal:  Trends Pharmacol Sci       Date:  2022-05-07       Impact factor: 17.638

3.  CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment.

Authors:  Fang Wang; Zhennan Tao; Zhen Tian; Jiaqi Jin; Jiawei Dong; Yuxiang Dai; Wanli Yu; Bin Tang; Shaoshan Hu
Journal:  Front Genet       Date:  2022-07-05       Impact factor: 4.772

4.  Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma.

Authors:  Wen-Hao Hsu; Fatima Khan; Madeline Dunterman; Lizhi Pang; Wenjing Xuan; Derek A Wainwright; Atique U Ahmed; Amy B Heimberger; Maciej S Lesniak; Peiwen Chen
Journal:  Cancer Immunol Res       Date:  2022-06-03       Impact factor: 12.020

5.  A 2-Gene Signature Related to Interferon-Gamma Predicts Prognosis and Responsiveness to Immune Checkpoint Blockade of Glioma.

Authors:  Yongzhe Li; Hang Ji; Xin Gao
Journal:  Front Med (Lausanne)       Date:  2022-04-15

Review 6.  Tumor-Associated Macrophages in Gliomas-Basic Insights and Treatment Opportunities.

Authors:  Johannes K Andersen; Hrvoje Miletic; Jubayer A Hossain
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

7.  Comprehensive Bioinformatics Analysis of Gasdermin Family of Glioma.

Authors:  Huaduan Zi; Zhan Tuo; Qianyuan He; Jingshu Meng; Yan Hu; Yan Li; Kunyu Yang
Journal:  Comput Intell Neurosci       Date:  2022-04-15

Review 8.  Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment.

Authors:  Zaixiang Fu; Ganggui Zhu; Chao Luo; Zihang Chen; Zhangqi Dou; Yike Chen; Chen Zhong; Sheng Su; Fuyi Liu
Journal:  Front Oncol       Date:  2022-08-12       Impact factor: 5.738

9.  Hypoxia-Driven M2-Polarized Macrophages Facilitate Cancer Aggressiveness and Temozolomide Resistance in Glioblastoma.

Authors:  Ge Zhang; Xiang Tao; Baowei Ji; Jie Gong
Journal:  Oxid Med Cell Longev       Date:  2022-08-22       Impact factor: 7.310

Review 10.  Circadian regulation of cancer cell and tumor microenvironment crosstalk.

Authors:  Wenjing Xuan; Fatima Khan; Charles David James; Amy B Heimberger; Maciej S Lesniak; Peiwen Chen
Journal:  Trends Cell Biol       Date:  2021-07-13       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.